Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel signature based on M6a modification regulators related LncRNA for stratification of the prognosis of prostate cancer. | Environ Toxicol | 2024 | 38156438 | PubTator, text mining | PubMed |
| Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cells. | iScience | 2024 | 38155775 | PubTator, text mining | PubMed |
| Exploring urinary modified nucleosides as biomarkers for diabetic retinopathy: Development and validation of a ultra performance liquid chromatography-tandem mass spectrometry method. | J Chromatogr B Analyt Technol Biomed Life Sci | 2024 | 38150972 | PubTator, text mining | PubMed |
| Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes. | Hum Mol Genet | 2024 | 38142284 | PubTator, text mining | PubMed |
| Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC. | Cancer Sci | 2024 | 38115228 | PubTator, text mining | PubMed |
| A low-cost, low-input method establishment for m6A MeRIP-seq. | Biosci Rep | 2024 | 38113135 | PubTator, text mining | PubMed |
| M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer. | Redox Biol | 2024 | 38104484 | PubTator, text mining | PubMed |
| ALKBH5 regulates ovarian cancer growth via demethylating long noncoding RNA PVT1 in ovarian cancer. | J Cell Mol Med | 2024 | 38098223 | PubTator, text mining | PubMed |
| DNA methylation regulates RNA m6A modification through transcription factor SP1 during the development of porcine somatic cell nuclear transfer embryos. | Cell Prolif | 2024 | 38095020 | PubTator, text mining | PubMed |
| Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis. | Brain | 2024 | 38071653 | PubTator, text mining | PubMed |
| Integrative analyses of N6-methyladenosine-associated single-nucleotide polymorphisms (m6A-SNPs) identify tumor suppressor gene AK9 in lung cancer. | Mol Carcinog | 2024 | 38051288 | PubTator, text mining | PubMed |
| M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3. | Cell Signal | 2024 | 38048860 | PubTator, text mining | PubMed |
| Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma. | Transl Oncol | 2024 | 38042135 | PubTator, text mining | PubMed |
| FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3. | Biochem Genet | 2024 | 38001392 | PubTator, text mining | PubMed |
| Machine learning-derived identification of prognostic signature for improving prognosis and drug response in patients with ovarian cancer. | J Cell Mol Med | 2024 | 37994489 | PubTator, text mining | PubMed |
| YTHDF1 facilitates PRC1-mediated H2AK119ub in human ES cells. | J Cell Physiol | 2024 | 37991435 | PubTator, text mining | PubMed |
| RMBase v3.0: decode the landscape, mechanisms and functions of RNA modifications. | Nucleic Acids Res | 2024 | 37956310 | PubTator, text mining | PubMed |
| SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A-mediated SLC7A11 expression and promoting aerobic glycolysis. | Environ Toxicol | 2024 | 37927237 | PubTator, text mining | PubMed |
| Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review. | Biomol Biomed | 2024 | 37877810 | PubTator, text mining | PubMed |
| Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma. | Recent Pat Anticancer Drug Discov | 2024 | 37877146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=17